Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons

BJU International

Volumn 90, Issue 2, 2002, Pages 162-173

  Quinn, M ^a   Babb, P ^a  

^a OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PREVALENCE; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; WORLD HEALTH;

EID: 0036065012     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.2822.x     Document Type: Article

References (99)

1. Estimates of the worldwide frequency of sixteen cancers in 1980
2. Estimates of the world-wide incidence of 25 major cancers in 1990
3. Cancer burden in the year 2000: The global picture
4. Risk factors for prostate cancer
5. Epidemiology of prostate cancer; with emphasis on familial clusters
6. Epidemiology of prostate cancer
7. Diagnosis, management and screening of early localised prostate cancer
8. The epidemiology of prostatic cancer
9. Alcohol consumption and risk of prostate cancer: The Harvard Alumni Health study
10. Sexual factors and the risk of prostate cancer
11. The epidemiology of prostate cancer: Clues for chemo-prevention
12. Localised prostatic cancer. Management and detection issues
13. Prostate cancer
14. Latent carcinoma of the prostate
15. Latent carcinoma of prostate at autopsy in seven areas
16. Prevalence of latent prostate carcinoma in two US populations
17. Detection of prostate cancer
18. Patterns of progression in prostate cancer
19. Radical prostatectomy for clinically localised prostate cancer. Long term results of 1,143 patients from a single institution
20. Control of prostate cancer with radiotherapy: Long term results
21. Recent results of conservative management of clinically localised prostate cancer
22. Population based study of long term survival in patients with clinically localised prostate cancer
23. Rise in prostatic cancer incidence associated with increased use of transurethral resection
24. Incidental adenocarcinoma in transurethral resections of the prostate. Partial versus complete microscopic examination
25. Variation in survival of patients with prostate cancer in Europe since 1978
26. The role of increasing detection in the rising incidence of prostate cancer
27. Cancer prevalence in European registries Areas
28. Prostate cancer
29. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-98
30. Mortality trends by cause of death in England and Wales 1980-94: The impact of introducing automated cause coding and related changes in 1993
31. Changing trends in prostatic cancer
32. Comparison of trends in prostate cancer mortality in England and Wales and the USA
33. Striking increase in incidence of prostate cancer men aged <60 years without improvement in prognosis
34. Rising incidence of prostate cancer in Scotland: Increased risk or increased detection?
35. Prostate cancer in Denmark: A 50-year population-based study
36. Trends in incidence of testicular cancer and prostate cancer in Denmark
37. A recent increase in the incidence of prostatic carcinoma in a French population: Role of ultrasonography and prostatic specific antigen
38. Cancer registration in Germany: Current status, perspectives and trends in incidence 1973-93
39. Prostatic cancer in the Grand Duchy of Luxembourg. Role of PSA
40. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands 1971-95
41. Increased risk of fatal prostate cancer may explain the rise in mortality in Netherlands
42. Time trends in cancer incidence in Navarra and Zaragoza, Spain
43. Incidence, mortality and survival from prostate cancer in Vaud Neuchatel, Switzerland, 1974-94
44. Prostate carcinoma incidence and mortality. The effects of screening and early detection
45. Analysis of recent trends in prostate cancer incidence and mortality
46. Cancer surveillance series: Interpreting trends in prostate cancer - Part III. Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality
47. National trends in the epidemiology of prostate cancer, 1973 to 94: Evidence for the effectiveness of prostate-specific antigen screening
48. Cancer surveillance series: Interpreting trends in prostate cancer - Part II. Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality
49. Cancer surveillance series: Interpreting trends in prostate cancer - Part I. Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality
50. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States
51. Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening
52. Impact of screening on prostate cancer rates and trends
53. Temporal trends in rates of prostate cancer: Declining incidence of advanced stage disease, 1974 to 1994
54. Trends in poorly differentiated prostate cancer 1973-94: Observations from the Surveillance, Epidemiology and End Results Database
55. Implications of stage specific survival rates in assessing recent declines in prostate cancer mortality rates
56. Prostate cancer trends in Canada: Rising incidence or increased detection?
57. Quebec prostate cancer mortality dropped in 1996
58. Downward trend in prostate cancer mortality in Quebec and Canada
59. Prostate cancer mortality trends in Mexico
60. Prostate cancer in Western Australia: Trends in incidence and mortality from 1985 to 1996
61. Prostate specific antigen testing in Australia and association with prostate cancer incidence in New South Wales
62. Prostate cancer mortality in New Zealand: The past and projections for the future
63. Trends and characteristics in prostate cancer mortality in Japan
64. International trends and patterns of prostate cancer incidence and mortality
65. The decline in cancer mortality in the European Union in 1988-96
66. Prostate cancer incidence and mortality trends among elderly and adult Europeans
67. The EUROCARE database
68. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare
69. Screening for breast cancer
70. Trends in breast cancer incidence, survival and mortality in England and Wales
71. Descriptive epidemiology. Statistical methods
72. Deprivation and mortality: An alternative to social class?
73. Relative survival and the estimate of net survival: Elements for further discussion